Consistent with our previous results (here as positive control), anti-PVRIG mAb significantly inhibited tumor growth (P < 0.0001) and prolonged overall survival (P < 0.0001) of tumor-bearing mice (Fig. 6d–g). The gene discussed is PVRIG; the disease is neoplasm.